By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mologen AG 

P.O. Box 332140

Berlin    D - 14180  Germany
Phone: 49-0-30-857-576-0 Fax: 49-0-30-857-576-50



Gene Therapy

Company News
Mologen AG (MOLGF.PK): Successful Investigator Meetings For IMPALA Colorectal Cancer Trial 10/20/2014 11:08:34 AM
Mologen AG (MOLGF.PK) Presents EnanDIM: A New Generation Of Immunomodulators 10/14/2014 10:53:05 AM
Mologen AG (MOLGF.PK): Three Poster Presentations At ESMO 2014 Congress 9/18/2014 1:06:27 PM
Mologen AG (MOLGF.PK): Initiation Of Phase 3 IMPALA Study With Immunotherapy MGN1703 In Colorectal 9/11/2014 9:52:11 AM
Mologen AG (MOLGF.PK): General Meeting Votes In Favour Of All Proposed Resolutions And Elects New Supervisory Board Members 8/15/2014 12:04:21 PM
Mologen AG (MOLGF.PK): Preparation And Launch Of New Studies Characterized The First Half-Year 2014 8/13/2014 1:01:20 PM
Mologen AG (MOLGF.PK): First Approvals For Phase III IMPALA Colorectal Cancer Study 8/4/2014 8:32:15 AM
Mologen AG (MOLGF.PK): Cancer Immune Therapy MGN1703 Shows Outstanding Long-Term Responses 6/30/2014 9:30:39 AM
Mologen AG (MOLGF.PK) To Present Two Posters At ESMO WCGI 2014 6/12/2014 8:02:47 AM
Mologen AG (MOLGF.PK): Development Of Main Product Candidate Pushed Forward Swiftly In First Quarter 5/14/2014 9:33:00 AM